Feb 2nd, 2017
Novo Nordisk CEO: Have Strong Growth Ahead in Diabetes
Lars Fruergaard Jorgensen, chief executive officer and president at Novo Nordisk, discusses President Trump's meeting with Pharma CEOs, the investments he's making in the U.S. and his outlook for growth. He speaks to Bloomberg's Guy Johnson on "Bloomberg Markets: European Open." (Source: Bloomberg)
